IBT
ITCI
International Biotechnology Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $16.5M | Buy |
317,856
+141,000
| +80% | +$7.34M | 5.57% | 4 |
|
|
2023
Q2 | $11.2M | Sell |
176,856
-81,000
| -31% | -$5.12M | 3.4% | 10 |
|
|
2023
Q1 | $14M | Buy |
257,856
+36,000
| +16% | +$1.95M | 3.89% | 7 |
|
|
2022
Q4 | $11.7M | Hold |
221,856
| – | – | 3.62% | 8 |
|
|
2022
Q3 | $10.3M | Buy |
221,856
+218,253
| +6,058% | +$10.1M | 3.3% | 8 |
|
|
2022
Q2 | $63.2K | Sell |
3,603
-47,353
| -93% | -$830K | 0.66% | 34 |
|
|
2022
Q1 | $20.9M | Sell |
50,956
-62,500
| -55% | -$25.7M | 4.72% | 4 |
|
|
2021
Q4 | $5.92M | Buy |
113,456
+34,000
| +43% | +$1.78M | 1.32% | 25 |
|
|
2021
Q3 | $2.96M | Hold |
79,456
| – | – | 0.71% | 32 |
|
|
2021
Q2 | $3.24M | Hold |
79,456
| – | – | 0.86% | 29 |
|
|
2021
Q1 | $2.7M | Hold |
79,456
| – | – | 0.71% | 28 |
|
|
2020
Q4 | $2.53M | Buy |
79,456
+54,656
| +220% | +$1.74M | 0.69% | 29 |
|
|
2020
Q3 | $637K | Buy |
24,800
+1,800
| +8% | +$46.2K | 0.21% | 48 |
|
|
2020
Q2 | $579K | Hold |
23,000
| – | – | 0.19% | 50 |
|
|
2020
Q1 | $352K | Buy |
+23,000
| New | +$352K | 0.16% | 53 |
|